Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mcL 41 44 41 44 I-lower_bound

As 0 2 45 47 O
a 3 4 48 49 O
part 5 9 50 54 O
of 10 12 55 57 O
the 13 16 58 61 O
OPEN 17 21 62 66 O
registration 22 34 67 79 O
process 35 42 80 87 O
the 43 46 88 91 O
treating 47 55 92 100 O
institution 56 67 101 112 O
's 67 69 112 114 O
identity 70 78 115 123 O
is 79 81 124 126 O
provided 82 90 127 135 O
in 91 93 136 138 O
order 94 99 139 144 O
to 100 102 145 147 O
ensure 103 109 148 154 O
that 110 114 155 159 O
the 115 118 160 163 O
current 119 126 164 171 O
( 127 128 172 173 O
within 128 134 173 179 O
365 135 138 180 183 B-upper_bound
days 139 143 184 188 I-upper_bound
) 143 144 188 189 O
date 145 149 190 194 O
of 150 152 195 197 O
institutional 153 166 198 211 O
review 167 173 212 218 O
board 174 179 219 224 O
approval 180 188 225 233 O
for 189 192 234 237 O
this 193 197 238 242 O
study 198 203 243 248 O
has 204 207 249 252 O
been 208 212 253 257 O
entered 213 220 258 265 O
in 221 223 266 268 O
the 224 227 269 272 O
system 228 234 273 279 O

Aspartate 0 9 280 289 B-clinical_variable
aminotransferase 10 26 290 306 I-clinical_variable
( 27 28 307 308 I-clinical_variable
AST 28 31 308 311 I-clinical_variable
) 31 32 311 312 I-clinical_variable
and 33 36 313 316 O
alanine 37 44 317 324 B-clinical_variable
aminotransferase 45 61 325 341 I-clinical_variable
( 62 63 342 343 I-clinical_variable
ALT 63 66 343 346 I-clinical_variable
) 66 67 346 347 I-clinical_variable
= 68 69 348 349 O
< 69 70 349 350 O
2.5 71 74 351 354 B-upper_bound
x 75 76 355 356 I-upper_bound
IULN 77 81 357 361 I-upper_bound

CT 0 2 362 364 B-treatment
or 3 5 365 367 O
MRI 6 9 368 371 B-treatment
with 10 14 372 376 O
contrast 15 23 377 385 O
as 24 26 386 388 O
part 27 31 389 393 O
of 32 34 394 396 O
PET 35 38 397 400 B-treatment
/ 38 39 400 401 I-treatment
CT 39 41 401 403 I-treatment
or 42 44 404 406 O
PET 45 48 407 410 B-treatment
/ 48 49 410 411 I-treatment
MRI 49 52 411 414 I-treatment

CT 0 2 415 417 B-treatment
or 3 5 418 420 O
MRI 6 9 421 424 B-treatment
without 10 17 425 432 O
contrast 18 26 433 441 O
as 27 29 442 444 O
part 30 34 445 449 O
of 35 37 450 452 O
positron 38 46 453 461 B-treatment
emission 47 55 462 470 I-treatment
tomography 56 66 471 481 I-treatment
[ 67 68 482 483 B-treatment
PET]/CT 68 75 483 490 I-treatment
or 76 78 491 493 I-treatment
PET 79 82 494 497 I-treatment
/ 82 83 497 498 I-treatment
MRI 83 86 498 501 I-treatment

CT 0 2 502 504 B-treatment
scans 3 8 505 510 I-treatment
or 9 11 511 513 O
MRIs 12 16 514 518 B-treatment
used 17 21 519 523 O
to 22 24 524 526 O
assess 25 31 527 533 O
disease 32 39 534 541 O
at 40 42 542 544 O
baseline 43 51 545 553 O
must 52 56 554 558 O
be 57 59 559 561 O
submitted 60 69 562 571 O
for 70 73 572 575 O
central 74 81 576 583 O
review 82 88 584 590 O

Hemoglobin 0 10 591 601 B-clinical_variable
> 11 12 602 603 O
= 12 13 603 604 O
9 14 15 605 606 B-lower_bound
g 16 17 607 608 I-lower_bound
/ 17 18 608 609 I-lower_bound
dL 18 20 609 611 I-lower_bound

No 0 2 612 614 O
evidence 3 11 615 623 O
of 12 14 624 626 O
metastatic 15 25 627 637 B-cancer
disease 26 33 638 645 I-cancer

No 0 2 646 648 O
involvement 3 14 649 660 O
, 14 15 660 661 O
or 16 18 662 664 O
< 19 20 665 666 O
180 21 24 667 670 B-upper_bound
Â° 24 25 670 671 I-upper_bound
interface 26 35 672 681 O
between 36 43 682 689 O
tumor 44 49 690 695 B-cancer
and 50 53 696 699 O
vessel 54 60 700 706 O
wall 61 65 707 711 O
, 65 66 711 712 O
of 67 69 713 715 O
the 70 73 716 719 O
portal 74 80 720 726 O
vein 81 85 727 731 O
and/or 86 92 732 738 O
superior 93 101 739 747 O
mesenteric 102 112 748 758 O
vein 113 117 759 763 O

No 0 2 764 766 O
prior 3 8 767 772 O
malignancy 9 19 773 783 B-cancer
is 20 22 784 786 O
allowed 23 30 787 794 O
except 31 37 795 801 O
for 38 41 802 805 O
adequately 42 52 806 816 O
treated 53 60 817 824 O
basal 61 66 825 830 B-cancer
( 67 68 831 832 O
or 68 70 832 834 O
squamous 71 79 835 843 B-cancer
cell 80 84 844 848 I-cancer
) 84 85 848 849 O
skin 86 90 850 854 B-cancer
cancer 91 97 855 861 I-cancer
, 97 98 861 862 O
in 99 101 863 865 B-cancer
situ 102 106 866 870 I-cancer
cervical 107 115 871 879 I-cancer
cancer 116 122 880 886 I-cancer
, 122 123 886 887 O
in 124 126 888 890 B-cancer
situ 127 131 891 895 I-cancer
breast 132 138 896 902 I-cancer
( 139 140 903 904 I-cancer
ductal 140 146 904 910 I-cancer
or 147 149 911 913 I-cancer
lobular 150 157 914 921 I-cancer
) 157 158 921 922 I-cancer
cancer 159 165 923 929 I-cancer
, 165 166 929 930 O
or 167 169 931 933 O
other 170 175 934 939 O
cancer 176 182 940 946 O
for 183 186 947 950 O
which 187 192 951 956 O
the 193 196 957 960 O
patient 197 204 961 968 O
has 205 208 969 972 O
been 209 213 973 977 O
disease 214 221 978 985 O
and 222 225 986 989 O
treatment 226 235 990 999 B-treatment
- 235 236 999 1000 O
free 236 240 1000 1004 O
for 241 244 1005 1008 O
two 245 248 1009 1012 B-upper_bound
years 249 254 1013 1018 I-upper_bound

Patients 0 8 1019 1027 O
must 9 13 1028 1032 O
have 14 18 1033 1037 O
a 19 20 1038 1039 O
Zubrod 21 27 1040 1046 B-clinical_variable
performance 28 39 1047 1058 I-clinical_variable
status 40 46 1059 1065 I-clinical_variable
of 47 49 1066 1068 O
0 50 51 1069 1070 B-lower_bound
- 51 52 1070 1071 O
1 52 53 1071 1072 B-upper_bound

Patients 0 8 1073 1081 O
must 9 13 1082 1086 O
have 14 18 1087 1091 O
histologically 19 33 1092 1106 O
or 34 36 1107 1109 O
cytologically 37 50 1110 1123 O
proven 51 57 1124 1130 O
pancreatic 58 68 1131 1141 B-cancer
adenocarcinoma 69 83 1142 1156 I-cancer

Patients 0 8 1157 1165 O
must 9 13 1166 1170 O
have 14 18 1171 1175 O
measurable 19 29 1176 1186 B-chronic_disease
disease 30 37 1187 1194 I-chronic_disease
in 38 40 1195 1197 O
the 41 44 1198 1201 O
pancreas 45 53 1202 1210 O

Patients 0 8 1211 1219 O
must 9 13 1220 1224 O
have 14 18 1225 1229 O
resectable 19 29 1230 1240 O
primary 30 37 1241 1248 B-cancer
tumor 38 43 1249 1254 I-cancer
based 44 49 1255 1260 O
on 50 52 1261 1263 O
contrast 53 61 1264 1272 B-treatment
- 61 62 1272 1273 I-treatment
enhanced 62 70 1273 1281 I-treatment
CT 71 73 1282 1284 I-treatment
or 74 76 1285 1287 O
MRI 77 80 1288 1291 B-treatment

Patients 0 8 1292 1300 O
must 9 13 1301 1305 O
have 14 18 1306 1310 O
surgical 19 27 1311 1319 B-treatment
consult 28 35 1320 1327 I-treatment
to 36 38 1328 1330 O
verify 39 45 1331 1337 O
patient 46 53 1338 1345 O
is 54 56 1346 1348 O
a 57 58 1349 1350 O
surgical 59 67 1351 1359 O
candidate 68 77 1360 1369 O
within 78 84 1370 1376 O
21 85 87 1377 1379 B-upper_bound
days 88 92 1380 1384 I-upper_bound
prior 93 98 1385 1390 I-upper_bound
to 99 101 1391 1393 O
registration 102 114 1394 1406 O

Patients 0 8 1407 1415 O
must 9 13 1416 1420 O
not 14 17 1421 1424 B-pregnancy
be 18 20 1425 1427 I-pregnancy
pregnant 21 29 1428 1436 I-pregnancy
or 30 32 1437 1439 O
nursing 33 40 1440 1447 O

Patients 0 8 1448 1456 O
must 9 13 1457 1461 O
not 14 17 1462 1465 O
have 18 22 1466 1470 O
received 23 31 1471 1479 O
prior 32 37 1480 1485 B-treatment
surgery 38 45 1486 1493 I-treatment
, 45 46 1493 1494 O
radiation 47 56 1495 1504 B-treatment
therapy 57 64 1505 1512 I-treatment
, 64 65 1512 1513 O
chemotherapy 66 78 1514 1526 B-treatment
, 78 79 1526 1527 O
targeted 80 88 1528 1536 B-treatment
therapy 89 96 1537 1544 I-treatment
, 96 97 1544 1545 O
or 98 100 1546 1548 O
any 101 104 1549 1552 O
investigational 105 120 1553 1568 B-treatment
therapy 121 128 1569 1576 I-treatment
for 129 132 1577 1580 O
pancreatic 133 143 1581 1591 B-cancer
cancer 144 150 1592 1598 I-cancer

Patients 0 8 1599 1607 O
with 9 13 1608 1612 O
uncontrolled 14 26 1613 1625 O
intercurrent 27 39 1626 1638 O
illness 40 47 1639 1646 O
including 48 57 1647 1656 O
, 57 58 1656 1657 O
but 59 62 1658 1661 O
not 63 66 1662 1665 O
limited 67 74 1666 1673 O
to 75 77 1674 1676 O
ongoing 78 85 1677 1684 O
or 86 88 1685 1687 O
active 89 95 1688 1694 B-chronic_disease
infection 96 105 1695 1704 I-chronic_disease
, 105 106 1704 1705 O
symptomatic 107 118 1706 1717 O
congestive 119 129 1718 1728 B-chronic_disease
heart 130 135 1729 1734 I-chronic_disease
failure 136 143 1735 1742 I-chronic_disease
, 143 144 1742 1743 O
unstable 145 153 1744 1752 B-chronic_disease
angina 154 160 1753 1759 I-chronic_disease
pectoris 161 169 1760 1768 O
, 169 170 1768 1769 O
cardiac 171 178 1770 1777 B-chronic_disease
arrhythmia 179 189 1778 1788 I-chronic_disease
, 189 190 1788 1789 O
or 191 193 1790 1792 O
psychiatric 194 205 1793 1804 B-chronic_disease
illness 206 213 1805 1812 I-chronic_disease
/ 213 214 1812 1813 O
social 214 220 1813 1819 O
situations 221 231 1820 1830 O
that 232 236 1831 1835 O
would 237 242 1836 1841 O
limit 243 248 1842 1847 O
compliance 249 259 1848 1858 O
with 260 264 1859 1863 O
study 265 270 1864 1869 O
requirements 271 283 1870 1882 O

Platelets 0 9 1883 1892 B-clinical_variable
> 10 11 1893 1894 O
= 11 12 1894 1895 O
100,000 13 20 1896 1903 B-lower_bound
/ 20 21 1903 1904 I-lower_bound
mcL 21 24 1904 1907 I-lower_bound

Serum 0 5 1908 1913 B-clinical_variable
albumin 6 13 1914 1921 I-clinical_variable
> 14 15 1922 1923 O
= 15 16 1923 1924 O
3 17 18 1925 1926 B-lower_bound
g 19 20 1927 1928 I-lower_bound
/ 20 21 1928 1929 I-lower_bound
dL 21 23 1929 1931 I-lower_bound

Serum 0 5 1932 1937 B-clinical_variable
creatinine 6 16 1938 1948 I-clinical_variable
= 17 18 1949 1950 O
< 18 19 1950 1951 O
IULN 20 24 1952 1956 B-upper_bound
within 25 31 1957 1963 O
14 32 34 1964 1966 B-upper_bound
days 35 39 1967 1971 I-upper_bound
prior 40 45 1972 1977 I-upper_bound
to 46 48 1978 1980 O
registration 49 61 1981 1993 O

Total 0 5 1994 1999 B-clinical_variable
bilirubin 6 15 2000 2009 I-clinical_variable
= 16 17 2010 2011 O
< 17 18 2011 2012 O
1.5 19 22 2013 2016 B-upper_bound
x 23 24 2017 2018 I-upper_bound
institutional 25 38 2019 2032 I-upper_bound
upper 39 44 2033 2038 I-upper_bound
limit 45 50 2039 2044 I-upper_bound
of 51 53 2045 2047 I-upper_bound
normal 54 60 2048 2054 I-upper_bound
( 61 62 2055 2056 I-upper_bound
IULN 62 66 2056 2060 I-upper_bound
) 66 67 2060 2061 I-upper_bound

all 0 3 2062 2065 O
disease 4 11 2066 2073 O
must 12 16 2074 2078 O
be 17 19 2079 2081 O
assessed 20 28 2082 2090 O
and 29 32 2091 2094 O
documented 33 43 2095 2105 O
on 44 46 2106 2108 O
the 47 50 2109 2112 O
baseline 51 59 2113 2121 O
tumor 60 65 2122 2127 B-cancer
assessment 66 76 2128 2138 O
form 77 81 2139 2143 O

computed 0 8 2144 2152 B-treatment
tomography 9 19 2153 2163 I-treatment
( 20 21 2164 2165 I-treatment
CT 21 23 2165 2167 I-treatment
) 23 24 2167 2168 I-treatment
scans 25 30 2169 2174 I-treatment
or 31 33 2175 2177 O
magnetic 34 42 2178 2186 O
resonance 43 52 2187 2196 I-treatment
imaging 53 60 2197 2204 I-treatment
( 61 62 2205 2206 I-treatment
MRIs 62 66 2206 2210 I-treatment
) 66 67 2210 2211 I-treatment
used 68 72 2212 2216 O
to 73 75 2217 2219 O
assess 76 82 2220 2226 O
measurable 83 93 2227 2237 O
disease 94 101 2238 2245 O
must 102 106 2246 2250 O
have 107 111 2251 2255 O
been 112 116 2256 2260 O
completed 117 126 2261 2270 O
within 127 133 2271 2277 O
28 134 136 2278 2280 B-upper_bound
days 137 141 2281 2285 I-upper_bound
prior 142 147 2286 2291 I-upper_bound
to 148 150 2292 2294 O
registration 151 163 2295 2307 O

for 0 3 2308 2311 O
tumors 4 10 2312 2318 B-cancer
of 11 13 2319 2321 O
the 14 17 2322 2325 O
body 18 22 2326 2330 O
and 23 26 2331 2334 O
tail 27 31 2335 2339 O
of 32 34 2340 2342 O
the 35 38 2343 2346 O
pancreas 39 47 2347 2355 O
, 47 48 2355 2356 O
involvement 49 60 2357 2368 O
of 61 63 2369 2371 O
the 64 67 2372 2375 O
splenic 68 75 2376 2383 O
artery 76 82 2384 2390 O
and 83 86 2391 2394 O
vein 87 91 2395 2399 O
of 92 94 2400 2402 O
any 95 98 2403 2406 O
degree 99 105 2407 2413 O
is 106 108 2414 2416 O
considered 109 119 2417 2427 O
resectable 120 130 2428 2438 B-cancer
disease 131 138 2439 2446 I-cancer

histologies 0 11 2447 2458 O
other 12 17 2459 2464 O
than 18 22 2465 2469 O
adenocarcinoma 23 37 2470 2484 B-cancer
, 37 38 2484 2485 O
or 39 41 2486 2488 O
any 42 45 2489 2492 O
mixed 46 51 2493 2498 O
histologies 52 63 2499 2510 O

women 0 5 2511 2516 B-gender
/ 5 6 2516 2517 I-gender
men 6 9 2517 2520 I-gender
of 10 12 2521 2523 O
reproductive 13 25 2524 2536 O
potential 26 35 2537 2546 O
must 36 40 2547 2551 O
have 41 45 2552 2556 O
agreed 46 52 2557 2563 B-contraception_consent
to 53 55 2564 2566 I-contraception_consent
use 56 59 2567 2570 I-contraception_consent
an 60 62 2571 2573 I-contraception_consent
effective 63 72 2574 2583 I-contraception_consent
contraceptive 73 86 2584 2597 I-contraception_consent
method 87 93 2598 2604 I-contraception_consent
for 94 97 2605 2608 O
up 98 100 2609 2611 O
to 101 103 2612 2614 O
3 104 105 2615 2616 B-upper_bound
months 106 112 2617 2623 I-upper_bound
after 113 118 2624 2629 I-upper_bound
the 119 122 2630 2633 O
final 123 128 2634 2639 O
administered 129 141 2640 2652 O
dose 142 146 2653 2657 O
of 147 149 2658 2660 O
chemotherapy 150 162 2661 2673 B-treatment

